Prevalence of migraine among adults with mood disorders: a Saudi cross-sectional study
Abstract
Migraine is characterized by recurrent headaches and frequently coexists with depressive and bipolar disorders, exacerbating disability and complicating management. Data on this association in Saudi Arabia remain limited, however. This study aims to investigate how mood disorders and migraine occur together in the Saudi context and understand the extent of disability that migraine may cause in patients with mood disorders. A cross-sectional study was conducted involving adult patients with mood disorders at a tertiary hospital in Riyadh, Saudi Arabia. Participants were recruited through convenience sampling. The research instrument consisted of a questionnaire developed by the research team to assess sociodemographic factors, along with the Arabic version of the Migraine Screen Questionnaire (MS-Q) for migraine screening and the Arabic version of the Migraine Disability Assessment Scale (MIDAS) to quantify migraine-related disability. A total of 206 participants were included, 10.68% of whom had a prior diagnosis of migraine and 20.87% screened positive for migraine on the MS-Q. The average MS-Q score was 1.48 ± 1.86 and MIDAS score 6.81 ± 19.3, indicating mild to moderate disability. Among those with migraine, 31.25% had severe migraine-related disability. The multivariate analysis identified female sex, psychiatric comorbidity, sleep quality, and family history of migraine as significant predictors for migraine. There was no correlation with age, income, employment status,…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 206 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.